1. Home
  2. CTSO vs DSY Comparison

CTSO vs DSY Comparison

Compare CTSO & DSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • DSY
  • Stock Information
  • Founded
  • CTSO 1997
  • DSY 2020
  • Country
  • CTSO United States
  • DSY China
  • Employees
  • CTSO N/A
  • DSY N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • DSY
  • Sector
  • CTSO Health Care
  • DSY
  • Exchange
  • CTSO Nasdaq
  • DSY Nasdaq
  • Market Cap
  • CTSO 72.8M
  • DSY 72.0M
  • IPO Year
  • CTSO N/A
  • DSY N/A
  • Fundamental
  • Price
  • CTSO $0.89
  • DSY $1.08
  • Analyst Decision
  • CTSO Buy
  • DSY
  • Analyst Count
  • CTSO 2
  • DSY 0
  • Target Price
  • CTSO $5.50
  • DSY N/A
  • AVG Volume (30 Days)
  • CTSO 351.0K
  • DSY 36.4K
  • Earning Date
  • CTSO 08-07-2025
  • DSY 01-01-0001
  • Dividend Yield
  • CTSO N/A
  • DSY N/A
  • EPS Growth
  • CTSO N/A
  • DSY 120.37
  • EPS
  • CTSO N/A
  • DSY 0.01
  • Revenue
  • CTSO $36,107,520.00
  • DSY $7,323,356.00
  • Revenue This Year
  • CTSO $11.15
  • DSY N/A
  • Revenue Next Year
  • CTSO $21.39
  • DSY N/A
  • P/E Ratio
  • CTSO N/A
  • DSY $86.24
  • Revenue Growth
  • CTSO 20.18
  • DSY 16.37
  • 52 Week Low
  • CTSO $0.71
  • DSY $0.95
  • 52 Week High
  • CTSO $1.61
  • DSY $6.98
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 41.50
  • DSY 35.76
  • Support Level
  • CTSO $1.03
  • DSY $1.07
  • Resistance Level
  • CTSO $1.19
  • DSY $1.11
  • Average True Range (ATR)
  • CTSO 0.09
  • DSY 0.09
  • MACD
  • CTSO 0.01
  • DSY -0.01
  • Stochastic Oscillator
  • CTSO 27.21
  • DSY 18.18

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About DSY Big Tree Cloud Holdings Limited Ordinary Shares

Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.

Share on Social Networks: